HAVLIDUR
Live / Applied — Third extension granted (statement of use) (as of 16 Sept 2025)
What this means for you
Not registered yet, but its 23 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98008957
- Mark type
- Stylized text
- Filed
- 23 May 2023
- Published for opposition
- 19 Mar 2024
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes
Owner
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
Prosecution history
- 17 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2025 — SOU EXTENSION 3 GRANTED
- 16 Sept 2025 — SOU EXTENSION 3 FILED
- 16 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Apr 2025 — SOU EXTENSION 2 GRANTED
- 14 Apr 2025 — SOU EXTENSION 2 FILED
- 14 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2024 — SOU EXTENSION 1 GRANTED
- 28 May 2024 — SOU EXTENSION 1 FILED
- 07 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 May 2024 — SOU TEAS EXTENSION RECEIVED
- 14 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED